☰

Lynne E. Rueter - Publications

Affiliations: 
Abbott Laboratories, Irving, TX, United States 
Area:
depression, schizophrenia, learning/memory
Tree Info Grants Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kohlhaas KL, Robb HM, Roderwald VA, Rueter LE. Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia. Biochemical Pharmacology. 97: 482-7. PMID 26032639 DOI: 10.1016/j.bcp.2015.05.011  0.318
2014 Brown JW, Rueter LE, Zhang M. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 49: 53-62. PMID 24269664 DOI: 10.1016/j.pnpbp.2013.11.008  0.505
2013 Brown JW, Whitehead CA, Basso AM, Rueter LE, Zhang M. Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 889-904. PMID 22906530 DOI: 10.1017/S1461145712000739  0.543
2012 Esbenshade TA, Browman KE, Miller TR, Krueger KM, Komater-Roderwald V, Zhang M, Fox GB, Rueter L, Robb HM, Radek RJ, Drescher KU, Fey TA, Bitner RS, Marsh K, Polakowski JS, et al. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 343: 233-45. PMID 22815533 DOI: 10.1124/Jpet.112.194126  0.489
2012 Kohlhaas KL, Bitner RS, Gopalakrishnan M, Rueter LE. Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis. Psychopharmacology. 220: 823-33. PMID 22038534 DOI: 10.1007/s00213-011-2535-6  0.506
2012 Lenz RA, Baker JD, Locke C, Rueter LE, Mohler EG, Wesnes K, Abi-Saab W, Saltarelli MD. The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology. 220: 97-107. PMID 21901320 DOI: 10.1007/S00213-011-2456-4  0.408
2011 Mohler EG, Browman KE, Roderwald VA, Cronin EA, Markosyan S, Scott Bitner R, Strakhova MI, Drescher KU, Hornberger W, Rohde JJ, Brune ME, Jacobson PB, Rueter LE. Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5406-13. PMID 21471376 DOI: 10.1523/Jneurosci.4046-10.2011  0.375
2011 Basso AM, Gallagher KB, Mikusa JP, Rueter LE. Vogel conflict test: sex differences and pharmacological validation of the model. Behavioural Brain Research. 218: 174-83. PMID 21115068 DOI: 10.1016/j.bbr.2010.11.041  0.325
2011 Zhang M, Ballard ME, Basso AM, Bratcher N, Browman KE, Curzon P, Konno R, Meyer AH, Rueter LE. Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity. Behavioural Brain Research. 217: 81-7. PMID 20933022 DOI: 10.1016/J.Bbr.2010.09.030  0.688
2011 Chin CL, Curzon P, Schwartz AJ, O'Connor EM, Rueter LE, Fox GB, Day M, Basso AM. Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia. Synapse (New York, N.Y.). 65: 393-403. PMID 20803618 DOI: 10.1002/Syn.20857  0.367
2011 Rueter LE, Rêlo AL, van Gaalen MM, Ballard ME, Terry AV, Buccafusco J, Zhang M. The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents/monkeys to humans: Preclinical evidences Biochemical Pharmacology. 82: 1043. DOI: 10.1016/J.Bcp.2011.07.052  0.673
2011 Kohlhaas KL, Robb H, Roderwald V, Markosyan S, Salte K, Bitner RS, Mohler E, Terry AV, Buccafusco J, Rueter LE, Lee L, Gopalakrishnan M. α7 NNR allosteric modulation in behavioral models of cognition Biochemical Pharmacology. 82: 1042. DOI: 10.1016/J.Bcp.2011.07.050  0.31
2010 Radek RJ, Kohlhaas KL, Rueter LE, Mohler EG. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists. Current Pharmaceutical Design. 16: 309-22. PMID 20109141 DOI: 10.2174/138161210790170166  0.459
2010 Mohler EG, Franklin SR, Rueter LE, Fox GB, Decker MW, Browman KE. ABT-594 improves performance in the 5-choice serial reaction time task under conditions of increased difficulty, sub-chronic dosing, and in poorly-performing subjects. Pharmacology, Biochemistry, and Behavior. 95: 146-57. PMID 20064548 DOI: 10.1016/J.Pbb.2009.12.019  0.359
2010 Basso AM, Curzon P, Zhang M, Gallagher KB, Salte K, Brown J, Nikkel AL, Bitner RS, Day M, Decker MW, Fox GB, Rueter LE, Chin C. NEONATAL TREATMENT WITH METHYLAZOXYMETHANOL ACETATE (MAM) AS A NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA: BEHAVIORAL, PHARMACOLOGICAL AND MORPHOLOGICAL CHARACTERIZATION Schizophrenia Research. 117: 272-273. DOI: 10.1016/J.Schres.2010.02.437  0.413
2009 Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behavioural Brain Research. 198: 83-90. PMID 18996151 DOI: 10.1016/j.bbr.2008.10.018  0.386
2007 Ji J, Bunnelle WH, Anderson DJ, Faltynek C, Dyhring T, Ahring PK, Rueter LE, Curzon P, Buckley MJ, Marsh KC, Kempf-Grote A, Meyer MD. A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models. Biochemical Pharmacology. 74: 1253-62. PMID 17854775 DOI: 10.1016/j.bcp.2007.08.010  0.388
2007 Zhang M, Ballard ME, Unger LV, Haupt A, Gross G, Decker MW, Drescher KU, Rueter LE. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine. Behavioural Brain Research. 182: 1-11. PMID 17570538 DOI: 10.1016/j.bbr.2007.04.021  0.705
2007 Ballard ME, Basso AM, Gallagher KB, Browman KE, Fox GB, Drescher KU, Gross G, Decker MW, Rueter LE, Zhang M. The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. Psychopharmacology. 190: 1-11. PMID 17093979 DOI: 10.1007/S00213-006-0577-Y  0.694
2006 Frost JM, Bunnelle WH, Tietje KR, Anderson DJ, Rueter LE, Curzon P, Surowy CS, Ji J, Daanen JF, Kohlhaas KL, Buckley MJ, Henry RF, Dyhring T, Ahring PK, Meyer MD. Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists. Journal of Medicinal Chemistry. 49: 7843-53. PMID 17181167 DOI: 10.1021/jm060846z  0.375
2006 Rueter LE, Donnelly-Roberts DL, Curzon P, Briggs CA, Anderson DJ, Bitner RS. A-85380: a pharmacological probe for the preclinical and clinical investigation of the alphabeta neuronal nicotinic acetylcholine receptor. Cns Drug Reviews. 12: 100-12. PMID 16958984 DOI: 10.1111/j.1527-3458.2006.00100.x  0.306
2006 Basso AM, Bratcher NA, Gallagher KB, Cowart MD, Zhao C, Sun M, Esbenshade TA, Brune ME, Fox GB, Schmidt M, Collins CA, Souers AJ, Iyengar R, Vasudevan A, Kym PR, ... ... Rueter LE, et al. Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety. European Journal of Pharmacology. 540: 115-20. PMID 16765941 DOI: 10.1016/J.Ejphar.2006.04.043  0.371
2006 Zhang M, Ballard ME, Kohlhaas KL, Browman KE, Jongen-Rêlo AL, Unger LV, Fox GB, Gross G, Decker MW, Drescher KU, Rueter LE. Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1382-92. PMID 16395300 DOI: 10.1038/Sj.Npp.1300985  0.712
2005 Fox GB, Esbenshade TA, Pan JB, Browman KE, Zhang M, Ballard ME, Radek RJ, Miner H, Bitner RS, Krueger KM, Yao BB, Faghih R, Rueter LE, Komater VA, Drescher KU, et al. Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 54: S23-4. PMID 15928819 DOI: 10.1007/S00011-004-0410-1  0.699
2005 Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Brain Research. 1045: 142-9. PMID 15910772 DOI: 10.1016/j.brainres.2005.03.018  0.724
2005 Dubé GR, Kohlhaas KL, Rueter LE, Surowy CS, Meyer MD, Briggs CA. Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain. Neuroscience Letters. 376: 29-34. PMID 15694269 DOI: 10.1016/j.neulet.2004.11.020  0.317
2005 Basso AM, Gallagher KB, Bratcher NA, Brioni JD, Moreland RB, Hsieh GC, Drescher K, Fox GB, Decker MW, Rueter LE. Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1257-68. PMID 15688083 DOI: 10.1038/sj.npp.1300677  0.417
2005 Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, et al. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 313: 176-90. PMID 15608077 DOI: 10.1124/Jpet.104.078402  0.723
2004 Browman KE, Komater VA, Curzon P, Rueter LE, Hancock AA, Decker MW, Fox GB. Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behavioural Brain Research. 153: 69-76. PMID 15219708 DOI: 10.1016/J.Bbr.2003.11.001  0.468
2004 Rueter LE, Ballard ME, Gallagher KB, Basso AM, Curzon P, Kohlhaas KL. Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology. 176: 312-9. PMID 15179541 DOI: 10.1007/s00213-004-1897-4  0.692
2004 Rueter LE, Anderson DJ, Briggs CA, Donnelly-Roberts DL, Gintant GA, Gopalakrishnan M, Lin NH, Osinski MA, Reinhart GA, Buckley MJ, Martin RL, McDermott JS, Preusser LC, Seifert TR, Su Z, et al. ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders. Cns Drug Reviews. 10: 167-82. PMID 15179445 DOI: 10.1111/J.1527-3458.2004.Tb00011.X  0.434
2004 Decker MW, Rueter LE, Bitner RS. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Current Topics in Medicinal Chemistry. 4: 369-84. PMID 14754452 DOI: 10.2174/1568026043451447  0.337
2003 Rueter LE, Kohlhaas KL, Curzon P, Surowy CS, Meyer MD. Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain. Pain. 103: 269-76. PMID 12791433 DOI: 10.1016/s0304-3959(02)00455-4  0.336
2000 Rueter LE, Meyer MD, Decker MW. Spinal mechanisms underlying A-85380-induced effects on acute thermal pain. Brain Research. 872: 93-101. PMID 10924680 DOI: 10.1016/S0006-8993(00)02472-0  0.355
2000 Meyer MD, Decker MW, Rueter LE, Anderson DJ, Dart MJ, Kim KH, Sullivan JP, Williams M. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain. European Journal of Pharmacology. 393: 171-7. PMID 10771011 DOI: 10.1016/S0014-2999(00)00041-8  0.355
1998 Rueter LE, de Montigny C, Blier P. In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain. Synapse (New York, N.Y.). 29: 392-405. PMID 9661257 DOI: 10.1002/(Sici)1098-2396(199808)29:4<392::Aid-Syn11>3.0.Co;2-T  0.308
1996 Mendlin A, Martín FJ, Rueter LE, Jacobs BL. Neuronal release of serotonin in the cerebellum of behaving rats: an in vivo microdialysis study. Journal of Neurochemistry. 67: 617-22. PMID 8764587 DOI: 10.1046/J.1471-4159.1996.67020617.X  0.302
Show low-probability matches.